| Schedule of derivative liability |
| Schedule of derivative liability | | |
| | |
| | |
| | |
| |
| Description | | |
Level 1 | | |
Level 2 | | |
Level 3 | | |
Total | |
| Derivative | | |
$ | — | | |
$ | — | | |
$ | 2,980,138 | | |
$ | 2,980,138 | |
| Total | | |
$ | — | | |
$ | — | | |
$ | 2,980,138 | | |
$ | 2,980,138 | |
The following table classifies the Company’s
liability measured at fair value on a recurring basis into the fair value hierarchy as of December 31, 2025:
| | |
| | |
| | |
| | |
| |
| Description | |
Level 1 | | |
Level 2 | | |
Level 3 | | |
Total | |
| Derivative | |
$ | — | | |
$ | — | | |
$ | 1,071,944 | | |
$ | 1,071,944 | |
| Total | |
$ | — | | |
$ | — | | |
$ | 1,071,944 | | |
$ | 1,071,944 | |
|
| Schedule of derivative liability | | |
| | |
| | |
| | |
| |
| Description | | |
Level 1 | | |
Level 2 | | |
Level 3 | | |
Total | |
| Derivative | | |
$ | — | | |
$ | — | | |
$ | 1,071,944 | | |
$ | 1,071,944 | |
| Total | | |
$ | — | | |
$ | — | | |
$ | 1,071,944 | | |
$ | 1,071,944 | |
The following table classifies the Company’s
liability measured at fair value on a recurring basis into the fair value hierarchy as of December 31, 2024:
| | |
| | |
| | |
| | |
| |
| Description | |
Level 1 | | |
Level 2 | | |
Level 3 | | |
Total | |
| Derivative | |
$ | — | | |
$ | — | | |
$ | 387,238 | | |
$ | 387,238 | |
| Total | |
$ | — | | |
$ | — | | |
$ | 387,238 | | |
$ | 387,238 | |
|
| Schedule of diluted net income (loss) per share available to common stockholders |
| Schedule of diluted net income (loss) per share available to common stockholders | |
| | |
| |
| | |
Three months ended March 31, | |
| | |
2026 | | |
2025 | |
| Warrants | |
| 2,422,222 | | |
| 2,950,000 | |
| Stock options | |
| 1,000,000 | | |
| 1,000,000 | |
| Common stock to be issued | |
| 4,254,113 | | |
| 5,855,261 | |
| Convertible notes payable | |
| 35,589,293 | | |
| 36,550,875 | |
| Embedded derivatives | |
| 70,008,281 | | |
| 1,849,420 | |
| Preferred stock | |
| 189,417,168 | | |
| 50,013,000 | |
| Total | |
| 302,691,077 | | |
| 98,218,556 | |
|
| Schedule of diluted net income (loss) per share available to common stockholders | |
| | |
| |
| | |
Year ended December 31, | |
| | |
2025 | | |
2024 | |
| Warrants | |
| 677,778 | | |
| 4,950,000 | |
| Stock options | |
| 1,000,000 | | |
| 1,000,000 | |
| Convertible notes payable | |
| 35,856,883 | | |
| 34,842,243 | |
| Common stock to be issued | |
| 13,663,352 | | |
| 2,973,132 | |
| Preferred stock | |
| 50,012,000 | | |
| 50,012,000 | |
| Embedded derivatives | |
| 31,204,555 | | |
| 3,543,165 | |
| Total | |
| 132,414,568 | | |
| 97,320,540 | |
|